Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer.
| Image |  |
|---|---|
| Description | scientific article published in October 2014 |
| Author/s |
author: Kazuhiro Araki Shunji Takahashi Rie Horii Ippei Fukada Takuji Iwase Futoshi Akiyama |
| Publication date | October 1, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |